Regeneron Pharma (REGN) PT Raised to $725 at BMO Capital
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $781.49 -1.48%
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Join SI Premium – FREE
BMO Capital analyst Evan David Seigerman raised the price target on Regeneron Pharma (NASDAQ: REGN) to $725.00 (from $640.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Regeneron Pharma (REGN) PT Raised to $920 at HSBC
- Oracle (ORCL) PT Lowered to $200 at Stifel, Buy Rating Maintained
- HubSpot Inc (HUBS) PT Raised to $225 at Stifel Ahead of UNBOUND Conference
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
